Datwyler Pharma Packaging India Profile
Key Indicators
- Authorised Capital ₹ 150.00 Cr
as on 26-07-2024
- Paid Up Capital ₹ 65.62 Cr
as on 26-07-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 66.38 Cr
as on 26-07-2024
- Revenue 17.72%
(FY 2023)
- Profit -17.91%
(FY 2023)
- Ebitda -6.14%
(FY 2023)
- Net Worth 21.01%
(FY 2023)
- Total Assets 13.67%
(FY 2023)
About Datwyler Pharma Packaging India
The Corporate was formerly known as New Helvoet Primary Packaging India Privatelimited. The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 150.00 Cr and a paid-up capital of Rs 65.62 Cr.
The company has closed loans amounting to ₹66.38 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Datwyler Pharma Packaging India Private Limited India are Amit Katekar as CFO and Priyanka Sonje as Company Secretary. Dirk Borghs, Rahul Dev, and Jurgen Steyls serve as directors at the Company.
- CIN/LLPIN
U25203PN2009PTC144482
- Company No.
144482
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Datwyler Pharma Packaging India?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Dev  | Managing Director | 15-Oct-2012 | Current |
| Amit Katekar | CFO | 18-Aug-2023 | Current |
| Priyanka Sonje | Company Secretary | 10-Mar-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jurgen Steyls  | Director | 27-Dec-2016 | Current |
| Dirk Borghs | Director | 03-Apr-2010 | Current |
Financial Performance and Corporate Structure Insights of Datwyler Pharma Packaging India.
Datwyler Pharma Packaging India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.72% increase. The company also saw a substantial fall in profitability, with a 17.91% decrease in profit. The company's net worth Soared by an impressive increase of 21.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Datwyler Pharma Packaging India?
In 2023, Datwyler Pharma Packaging India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
7 years 3 days Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bnp Paribas Creation Date: 10 Apr 2012 | ₹66.38 Cr | Satisfied |
How Many Employees Work at Datwyler Pharma Packaging India?
Datwyler Pharma Packaging India has a workforce of 316 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Oct 15, 2014, Datwyler Pharma Packaging India has raised a total of ₹ 141.37 Cr, with the most recent deal valued at ₹ 15.64 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
